Beta Bionics, Inc. (BBNX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $671.99M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-390.00K; Retained Earnings (Accumulated Deficit)USD $-415.24M.
- 2026-03-31: Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $663.17M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-96.00K; Retained Earnings (Accumulated Deficit)USD $-391.83M.
- 2025-12-31: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in CapitalUSD $657.14M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $403.00K; Retained Earnings (Accumulated Deficit)USD $-369.94M.
- 2025-09-30: Common Stock, Value, IssuedUSD $4.00K; Additional Paid in CapitalUSD $650.87M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $354.00K; Retained Earnings (Accumulated Deficit)USD $-356.47M.
Beta Bionics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00K | $671.99M | $-390.00K | $-415.24M | $256.37M | 3 month · $7.02M 6 month · $12.42M |
| 2026-03-31 | $5.00K | $663.17M | $-96.00K | $-391.83M | $271.25M | 3 month · $5.41M |
| 2025-12-31 | $4.00K | $657.14M | $403.00K | $-369.94M | $287.61M | 12 month · $16.38M |
| 2025-09-30 | $4.00K | $650.87M | $354.00K | $-356.47M | $294.76M | 3 month · $4.48M 9 month · $12.08M |
| 2025-06-30 | $4.00K | $643.74M | $149.00K | $-342.26M | $301.63M | 3 month · $4.80M 6 month · $7.60M |
| 2025-03-31 | $4.00K | $638.90M | $240.00K | $-325.39M | $313.75M | 3 month · $2.80M |
| 2024-12-31 | $1.00K | $51.31M | $65.00K | $-296.74M | $-245.36M | 12 month · $6.38M |
| 2024-09-30 | (m) | (m) | (m) | (m) | $-228.85M | 3 month · $1.98M 9 month · $4.83M |
| 2024-06-30 | (m) | (m) | (m) | (m) | $-221.21M | 3 month · $1.50M 6 month · $2.86M |
| 2024-03-31 | (m) | (m) | (m) | (m) | $-214.32M | 3 month · $1.36M |
| 2023-12-31 | (m) | $26.42M | $137.00K | $-229.66M | $-203.10M | 12 month · $5.66M |
| 2022-12-31 | (m) | (m) | (m) | (m) | $-170.03M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |